Victory Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,666
| Closed | -$243K | – | 2600 |
|
|
2022
Q3 | $243K | Buy |
42,666
+699
| +2% | +$3.98K | ﹤0.01% | 2310 |
|
|
2022
Q2 | $298K | Sell |
41,967
-1,924
| -4% | -$13.7K | ﹤0.01% | 2239 |
|
|
2022
Q1 | $258K | Sell |
43,891
-42,119
| -49% | -$248K | ﹤0.01% | 2347 |
|
|
2021
Q4 | $769K | Buy |
86,010
+78,187
| +999% | +$699K | ﹤0.01% | 1947 |
|
|
2021
Q3 | $274K | Buy |
+7,823
| New | +$274K | ﹤0.01% | 2413 |
|
|
2021
Q2 | – | Sell |
-7,088
| Closed | -$438K | – | 2749 |
|
|
2021
Q1 | $438K | Buy |
+7,088
| New | +$438K | ﹤0.01% | 2256 |
|